This is correct an entirely different mechanism of action than Travere which was conveniently not mentioned. Comparing apples with oranges.
ADVANZ upfront +A$10m payment I'm sure their medical experts would have conducted extensive due diligence before signing the dotted line. DXB still have bigger and much more lucrative regions in negotiations the size of the deals will dwarf ADVANZ. These deals could land at any given time.
Ann: Dimerix Announces License Agreement for EU, Canada, ANZ, page-388
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
53.0¢ |
Change
0.020(3.92%) |
Mkt cap ! $291.6M | |||
| Open | High | Low | Value | Volume |
| 51.0¢ | 53.8¢ | 51.0¢ | $782.0K | 1.490M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6408 | 53.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 53.5¢ | 35657 | 1 |
View Market Depth
| Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |